PPARGC1A and fatty liver disease: Mouse models showed that physiological reductions of PGC‐1α disrupt insulin signalling in liver,53 and mice with low hepatic PGC‐1α are more susceptible to hepatic steatosis, hypertriglyceridaemia, and oxidative liver damage – hallmarks of insulin resistance.17, 53